Sarepta Therapeutics (NASDAQ:SRPT) Raised to “Sector Outperform” at Scotiabank
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) was upgraded by analysts at Scotiabank from a “sector perform” rating to a “sector outperform” rating in a note issued to investors on Friday, Marketbeat Ratings reports. The firm currently has a $80.00 price target on the biotechnology company’s stock. Scotiabank’s price target would indicate a potential upside […]
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) was upgraded by analysts at Scotiabank from a “sector perform” rating to a “sector outperform” rating in a note issued to investors on Friday, Marketbeat Ratings reports. The firm currently has a $80.00 price target on the biotechnology company’s stock. Scotiabank’s price target would indicate a potential upside […]
